SCHEMBL6706533

SCHEMBL6706533

CCOC(=O)c1ccc(CCC2CCNCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ESR1 P03372 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
ESR2 Q92731 1/20 0.46
CA14 Q9ULX7 1/20 0.46
RAB9A P51151 2/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAOA P21397 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KCNJ1 P48048 1/20 0.44
KCNH2 Q12809 1/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17996041 0.87 RAB9A (0.51) CA12CA1CA2ESR1CA7
SCHEMBL11060990 0.86 CA12 (0.49) CA12CA1CA2ESR1CA7
SCHEMBL16664043 0.86 RAB9A (0.50) CA12CA1CA2ESR1CA7
SCHEMBL11055087 0.86 CA12 (0.49) CA12CA1CA2ESR1CA7
SCHEMBL11055080 0.86 CA12 (0.49) CA12CA1CA2ESR1CA7
SCHEMBL11060994 0.86 CA12 (0.49) CA12CA1CA2ESR1CA7
SCHEMBL24663844 0.86 GBA1 (0.49) CA12CA1CA2ESR1CA7
SCHEMBL27670154 0.86 CYP4A11 (0.51) ITGB3ITGA2BCYP1A2CYP3A4SMN1; SMN2
Hydrochloric Acid SCHEMBL22532937 0.85 GBA1 (0.47) CA12CA1CA2ESR1CA7
SCHEMBL11061908 0.84 DRD2 (0.47) CA12CA1CA2ESR1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof NPY1R, ADCY1, SRD5A1 CA12 619/4885CA1 153/4885CA2 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.